Pyrrolocarbazoles as Checkpoint 1 Kinase Inhibitors

Author(s): Helene Henon, Elisabeth Conchon, Bernadette Hugon, Samir Messaoudi, Roy M. Golsteyn, Michelle Prudhomme

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 8 , Issue 6 , 2008

Become EABM
Become Reviewer


The carbazole framework is found in many natural compounds of biological interest. Indolocarbazoles such as rebeccamycin and staurosporine which are either a topoisomerase I inhibitor (rebeccamycin) or a non selective kinase inhibitor (staurosporine) are bacterial metabolites. In the search for new antitumor agents, DNA damage checkpoint kinases, in particular Checkpoint kinase 1, have recently emerged as attractive targets for cancer therapy. This review reports the synthesis and Chk1 inhibitory activities of pyrrolocarbazole compounds bearing four or five fused rings.

Keywords: Checkpoint kinase 1, antitumor agents, pyrrolocarbazole, granulatimide

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [577 - 597]
Pages: 21
DOI: 10.2174/187152008785133100
Price: $65

Article Metrics

PDF: 6